1. Home
  2. GFR vs VOR Comparison

GFR vs VOR Comparison

Compare GFR & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenfire Resources Ltd.

GFR

Greenfire Resources Ltd.

N/A

Current Price

$7.73

Market Cap

924.7M

Sector

N/A

ML Signal

N/A

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

N/A

Current Price

$19.40

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GFR
VOR
Founded
2018
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
924.7M
1.1B
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
GFR
VOR
Price
$7.73
$19.40
Analyst Decision
Sell
Strong Buy
Analyst Count
3
10
Target Price
$7.72
★ $39.00
AVG Volume (30 Days)
★ 1.6M
677.6K
Earning Date
11-09-2026
10-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$142.30
N/A
P/E Ratio
$4.33
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.15
$6.50
52 Week High
$7.81
$26.00

Technical Indicators

Market Signals
Indicator
GFR
VOR
Relative Strength Index (RSI) 65.18 49.10
Support Level $5.63 $17.62
Resistance Level N/A $20.11
Average True Range (ATR) 0.23 1.20
MACD 0.14 0.08
Stochastic Oscillator 96.46 44.06

Price Performance

Historical Comparison
GFR
VOR

About GFR Greenfire Resources Ltd.

Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations. The company is actively developing its Hangingstone Facilities using SAGD, an enhanced oil recovery extraction method.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: